Live data · NADAC + Part D CY24 · reviewed daily

Estrogens, Conjugated (Conjugated Estrogens)

Estrogens, Conjugated supplements estrogen levels, used in hormone replacement therapy and contraception.

First FDA approval2004-09-01
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$367.7M in CY2024 Part D spend897K claims · 383K beneficiaries · 329 plans surveyed

Lowest NADAC
$5.43/unit
12 NDCs benchmarked, lowest of all strengths.
Average NADAC
$6.53
Across all dosage forms in distribution.
Highest NADAC
$6.97
Range is tight.
Plans with PA
95 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Estrogens, Conjugated used for?

Estrogens, Conjugated supplements estrogen levels, used in hormone replacement therapy and contraception.

Is there a generic for Estrogens, Conjugated?

Yes. 5 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Estrogens, Conjugated?

Across 329 Part D plans, Estrogens, Conjugated averages $6.53/unit (NADAC). Lowest available: $5.43/unit. Highest in distribution: $6.97/unit.

Is Estrogens, Conjugated on the FDA shortage list?

No. Estrogens, Conjugated is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Estrogen6 alternatives in D1
01
Estradiol
Brand: Climara
$0.059Lowest NADAC
21Generic mfrs
$605.7MCY24 Part D spend
Compare →
02
$0.131Lowest NADAC
17Generic mfrs
CY24 Part D spend
Compare →
03
$0.113Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
$0.131Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
$0.711Lowest NADAC
6Generic mfrs
CY24 Part D spend
Compare →
06
$8.67Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh14 Jul 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.